GeneKor MSA
General information
GeneKor MSA
Spaton 52, Ave., Gerakas
Athens
Attiki
Greece - 15344
http://www.genekor.com/
Organization ID: 505504
Spaton 52, Ave., Gerakas
Athens
Attiki
Greece - 15344
http://www.genekor.com/
Organization ID: 505504
Personnel
- George Nasioulas, Lab Director
Phone: +30 210 6032138
Email: gnasioulas@genekor.com - George Tsaousis, Informatics staff
Phone: +30 210 6032138
Email: gtsaousis@genekor.com
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 1326
Gene
| Gene | Submissions | Last Updated |
|---|---|---|
| ABRAXAS1 | 7 | Jul 14, 2025 |
| APC | 50 | Jul 14, 2025 |
| ATM | 115 | Jul 14, 2025 |
| ATR | 17 | Jul 14, 2025 |
| AXIN2 | 9 | Jul 14, 2025 |
| BARD1 | 27 | Jul 14, 2025 |
| BLM | 30 | Jul 14, 2025 |
| BMPR1A | 9 | Jul 14, 2025 |
| BRCA1 | 148 | Jul 14, 2025 |
| BRCA2 | 260 | Jul 14, 2025 |
| BRIP1 | 27 | Jul 14, 2025 |
| C11orf65 | 45 | Jul 14, 2025 |
| CDH1 | 17 | Jul 14, 2025 |
| CDK4 | 6 | Jul 14, 2025 |
| CDKN2A | 7 | Jul 14, 2025 |
| CHEK1 | 1 | Aug 8, 2018 |
| CHEK2 | 34 | Jul 14, 2025 |
| DCTN5 | 1 | Mar 6, 2020 |
| DHFR | 8 | Jul 14, 2025 |
| EPCAM | 7 | Jul 14, 2025 |
| FANCA | 53 | Jul 14, 2025 |
| FANCL | 7 | Jul 14, 2025 |
| FANCM | 13 | Jul 14, 2025 |
| FBXO11 | 1 | Jul 14, 2025 |
| GALNT12 | 3 | Jul 14, 2025 |
| GEN1 | 13 | Jul 14, 2025 |
| GREM1 | 2 | Jul 14, 2025 |
| LOC106721785 | 2 | Nov 21, 2017 |
| LOC106736614 | 1 | Aug 8, 2018 |
| LOC107303340 | 2 | Aug 8, 2018 |
| LOC111589215 | 1 | Nov 21, 2017 |
| LOC112486223 | 2 | Jul 14, 2025 |
| LOC126862571 | 19 | Jul 14, 2025 |
| LOC129390903 | 2 | Aug 8, 2018 |
| LOC129933707 | 1 | Jul 14, 2025 |
| LOC129935544 | 3 | Jul 14, 2025 |
| LOC130004245 | 1 | Jul 14, 2025 |
| LOC130006700 | 1 | Jul 14, 2025 |
| LOC130009266 | 1 | Jul 14, 2025 |
| LOC130059837 | 2 | Jul 14, 2025 |
| LOC132090450 | 1 | Jul 14, 2025 |
| MEN1 | 13 | Jul 14, 2025 |
| MITF | 1 | Jul 14, 2025 |
| MLH1 | 35 | Jul 14, 2025 |
| MRE11 | 17 | Jul 14, 2025 |
| MSH2 | 28 | Jul 14, 2025 |
| MSH3 | 17 | Jul 14, 2025 |
| MSH6 | 43 | Jul 14, 2025 |
| MUTYH | 17 | Jul 14, 2025 |
| NBN | 21 | Jul 14, 2025 |
| NF1 | 22 | Jul 14, 2025 |
| PALB2 | 33 | Jul 14, 2025 |
| PMS2 | 40 | Jul 14, 2025 |
| POLD1 | 6 | Jul 14, 2025 |
| POLE | 7 | Jul 14, 2025 |
| PPP2R2A | 4 | Jul 14, 2025 |
| PTEN | 5 | Jul 14, 2025 |
| RAD50 | 33 | Jul 14, 2025 |
| RAD51B | 15 | Jul 14, 2025 |
| RAD51C | 10 | Jul 14, 2025 |
| RAD51D | 15 | Jul 14, 2025 |
| RAD51L3-RFFL | 15 | Jul 14, 2025 |
| RET | 27 | Jul 14, 2025 |
| RNF43 | 8 | Jul 14, 2025 |
| RPS20 | 4 | Jul 14, 2025 |
| SMAD4 | 1 | Aug 8, 2018 |
| SMARCA4 | 8 | Jul 14, 2025 |
| STK11 | 11 | Jul 14, 2025 |
| TH2-LCR | 1 | Aug 8, 2018 |
| TH2LCRR | 5 | Jul 14, 2025 |
| TP53 | 15 | Jul 14, 2025 |
| TSPAN31 | 3 | Aug 8, 2018 |
| VHL | 7 | Jul 14, 2025 |
| VRK2 | 3 | Jul 14, 2025 |
| XRCC2 | 3 | Mar 6, 2020 |
| ZNF276 | 5 | Jul 14, 2025 |
Condition
| Name | Submissions | Last Updated |
|---|---|---|
| Breast-ovarian cancer, familial, susceptibility to, 1 | 5 | Mar 6, 2020 |
| Familial cancer of breast | 54 | Sep 29, 2021 |
| Fanconi anemia | 13 | Jul 14, 2025 |
| Fanconi anemia complementation group A | 53 | Jul 14, 2025 |
| Fanconi anemia complementation group L | 7 | Jul 14, 2025 |
| Hereditary breast ovarian cancer syndrome | 156 | Jul 14, 2025 |
| Hereditary cancer-predisposing syndrome | 811 | Jul 14, 2025 |
| Hereditary nonpolyposis colon cancer | 1 | Sep 20, 2022 |
| Lynch syndrome | 51 | Jul 14, 2025 |
| Melanoma-pancreatic cancer syndrome | 5 | Jul 14, 2025 |
| Multiple endocrine neoplasia, type 1 | 1 | Jul 14, 2025 |
| Ovarian cancer | 4 | Jan 7, 2020 |
| not provided | 98 | Sep 29, 2021 |
| not specified | 67 | Nov 21, 2017 |
Testing in GTR
| Disease name | Number of tests |
|---|---|
| Acute lymphoid leukemia | 1 test |
| Acute myeloid leukemia | 1 test |
| Anaplastic large cell lymphoma | 1 test |
| Attenuated familial adenomatous polyposis | 2 tests |
| Breast adenocarcinoma | 1 test |
| Breast lobular carcinoma | 1 test |
| Breast neoplasm | 2 tests |
| Breast-ovarian cancer, familial, susceptibility to, 1 | 1 test |
| Breast-ovarian cancer, familial, susceptibility to, 2 | 1 test |
| Carcinoma of colon | 2 tests |
| Carcinoma of pancreas | 2 tests |
| Chronic myelogenous leukemia, BCR-ABL1 positive | 1 test |
| Endometrial carcinoma | 2 tests |
| Familial adenomatous polyposis 1 | 2 tests |
| Familial cancer of breast | 3 tests |
| Familial colorectal cancer | 4 tests |
| Familial medullary thyroid carcinoma | 1 test |
| Familial pancreatic carcinoma | 2 tests |
| Gardner syndrome | 2 tests |
| Gastrointestinal stromal tumor | 1 test |
| Glioma | 1 test |
| Hereditary breast ovarian cancer syndrome | 1 test |
| Hereditary diffuse gastric adenocarcinoma | 1 test |
| Lung carcinoma | 1 test |
| Lynch syndrome | 3 tests |
| Melanoma | 2 tests |
| Mismatch repair cancer syndrome 1 | 3 tests |
| Muir-Torré syndrome | 2 tests |
| Multiple endocrine neoplasia type 2A | 1 test |
| Multiple endocrine neoplasia type 2B | 1 test |
| Multiple endocrine neoplasia, type 1 | 1 test |
| Multiple endocrine neoplasia, type 2 | 1 test |
| Myelodysplastic syndrome | 1 test |
| Non-small cell lung carcinoma | 1 test |
| Ovarian cancer | 1 test |
| Ovarian neoplasm | 3 tests |
| Solid tumor | 1 test |
| Thyroid gland carcinoma | 1 test |
| Von Hippel-Lindau syndrome | 1 test |